LY-2886721 - CAS# 1262036-50-9 60228 At a dose of 10

At a dose of 10 μM

Smiles: O=C1C=C(OC2=C1C=CC=C2C1C=CC=CC=1)N1CCOCC1

AZD-2281 is applied to SW620 cell lysates

Acalabrutinib (100 mg twice per day) assessed for thrombus formation at injured arterioles of the mice

PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3

LY-2886721 - CAS# 1262036-50-9 60228 At a dose of 10LY2886721, CAS No. 1262036 50 9, is an BACE inhibitor used for the treatment of Alzheimer's Disease. IC50 value: Target: BACE LY2886721 is a novel potent agent that is used to treat Alzheimers Disease in preclinical experiments. LY2886721 is under clinical study. A Safety Study of LY2886721 Multiple Doses is performing in Healthy Subjects. Product information CAS Number: 1262036 50 9 Molecular Weight: 390. 41 Formula: C18H16F2N4O2S Chemical Name: N (3